Literature DB >> 1285733

Possible association of malignant hyperthermia with sevoflurane anesthesia.

R Ochiai1, Y Toyoda, I Nishio, J Takeda, H Sekiguchi, K Fukushima, E Kohda.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1285733     DOI: 10.1213/00000539-199204000-00027

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


× No keyword cloud information.
  6 in total

Review 1.  Sevoflurane in paediatric anaesthesia: a review.

Authors:  K L Goa; S Noble; C M Spencer
Journal:  Paediatr Drugs       Date:  1999 Apr-Jun       Impact factor: 3.022

2.  Anesthetic management for a patient with oculocerebrorenal (Lowe's) syndrome.

Authors:  Hisao Komatsu; Masatomo Sakakibara; Yutaka Yoshimura; Hiroyuki Kinoshita; Satoshi Yokono; Kenji Ogli
Journal:  J Anesth       Date:  1994-03       Impact factor: 2.078

Review 3.  Sevoflurance: approaching the ideal inhalational anesthetic. a pharmacologic, pharmacoeconomic, and clinical review.

Authors:  L Delgado-Herrera; R D Ostroff; S A Rogers
Journal:  CNS Drug Rev       Date:  2001

Review 4.  Sevoflurane. A review of its pharmacodynamic and pharmacokinetic properties and its clinical use in general anaesthesia.

Authors:  S S Patel; K L Goa
Journal:  Drugs       Date:  1996-04       Impact factor: 9.546

5.  Effect of cocaine on the contracture response to 1% halothane in patients undergoing diagnostic muscle biopsy for malignant hyperthermia.

Authors:  N Sato; J M Brum; H Mitsumoto; G E DeBoer
Journal:  Can J Anaesth       Date:  1995-02       Impact factor: 5.063

6.  Malignant hyperthermia developing during esophageal resection in an 82-year-old man.

Authors:  Norihito Nakamura; Tomomi Ueda; Reiri Ishikawa; Yosuke Tasaka; Kiyoshi Fukuuchi; Nobukazu Sato
Journal:  J Anesth       Date:  2008-11-15       Impact factor: 2.078

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.